C12Q 2537/113
Heteroduplex formation
C12Q2537/113 (Heteroduplex formation) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12Q- Granted patents
- 3
- Published applications
- 5
- Assignees
- 6
- Inventors
- 17
- Latest grant
- 11 Feb 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Thromboembolic disease markers11 Feb 2020US 10,557,170 B2Gendiag.exe, S.L.
- Chromatographic method for mutation detection using mutation site specifically acting enzymes and chemicals22 Feb 2000US 6,027,898 ATransgenomic, Inc.
- Heteroduplex tracking assay (HTA) for genotyping HCV22 Dec 1998US 5,851,759 AChiron Corporation
- Single molecule nucleic acid detection by mismatch cleavage2 Oct 2025US 2025/0305033 A1Roche Sequencing Solutions, Inc.
- Hybridizing all-lna oligonucleotides23 Jun 2022US 2022/0195497 A1Roche Diagnostics Operations, Inc.
- Single molecule nucleic acid detection by mismatch cleavage3 Jun 2021US 2021/0164016 A1Stratos Genomics, Inc.
- Hybridizing all-lna oligonucleotides27 May 2021US 2021/0155976 A1Roche Diagnostics Operations, Inc.
- Thromboembolic disease markers8 Mar 2018US 2018/0066313 A1Gendiag.exe, S.L.
Most cited
By later US patents